Influence of a Combined Pharmacogenetic Score on Through Plasma Voriconazole Concentrations in Haematological Patients
CompletedOBSERVATIONAL
Enrollment
47
Participants
Timeline
Start Date
January 31, 2015
Primary Completion Date
January 31, 2019
Study Completion Date
January 31, 2019
Conditions
Invasive AspergillosisHaematological Cancer PatientsVoriconazole
Trial Locations (1)
38043
University Hospital, Grenoble Alpes, Grenoble
All Listed Sponsors
lead
University Hospital, Grenoble
OTHER
NCT03067350 - Influence of a Combined Pharmacogenetic Score on Through Plasma Voriconazole Concentrations in Haematological Patients | Biotech Hunter | Biotech Hunter